Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Acorda Therapeutics, Inc. today announced that it has acquired two neuropathic pain management assets from NeurogesX, Inc. Qutenza is approved by the U.S. Food and Drug Administration for the management of neuropathic pain associated with postherpetic neuralgia.

9 Jul 2013

Drugs used to control BP associated with lower risk of heart failure in diabetic patients

Two drugs, telmisartan and valsartan, which are used to reduce blood pressure in people with diabetes, are associated with a lower risk of hospitalization for heart attack, stroke or heart failure, according to a study published in CMAJ (Canadian Medical Association Journal).

9 Jul 2013

Capricor to become wholly-owned subsidiary of Nile Therapeutics

Capricor, Inc., a privately held biotechnology company developing cardiac stem cell therapeutics to repair damaged heart muscle, and Nile Therapeutics, Inc. announced today that they have entered into a Merger Agreement under which Capricor will become a wholly-owned subsidiary of Nile Therapeutics, Inc. in an all-stock transaction.

8 Jul 2013

Saint Luke's Hospital opens Charles & Barbara Duboc Cardio Health & Wellness Center

The Charles & Barbara Duboc Cardio Health & Wellness Center is ushering in a new era for preventive cardiac care at Saint Luke's Hospital.

6 Jul 2013

Study says screening heart with natriuretic peptide may reduce risk of dysfunction, heart failure

Among patients at risk of heart failure, collaborative care based on screening for certain levels of brain-type natriuretic peptide reduced the combined rates of left ventricular systolic dysfunction, diastolic dysfunction, and heart failure as well as emergency cardiovascular hospitalizations, according to a study in the July 3 issue of JAMA.

3 Jul 2013

Fondation Leducq grants $6M to cardiovascular scientists to help advance cardiac regeneration therapeutics

The Fondation Leducq in Paris, France, dedicated to improving human health through international efforts to combat cardiovascular disease, awarded a $6 million grant award to a new global research network of cardiovascular scientists which includes three researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.

2 Jul 2013

Hospitals, doctors consider changes amid Medicare hospital readmissions scrutiny

Hospitals and doctors are feeling the health care law heat as officials try to reduce readmissions and increase quality of care in the Medicare program. PBS NewsHour looks at the law's hospital readmissions penalties and Medpage Today explains what the hospitals are doing.

2 Jul 2013

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.

2 Jul 2013

First Edition: July 1, 2013

Today's headlines include a variety of weekend news reports, including coverage of the Obama administration's final contraceptive coverage rule as well as a range of other stories on health law implementation issues.

1 Jul 2013

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization to the European Medicines Agency for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

1 Jul 2013

Study shows lymphatic circulatory system may be intimately involved in vascular disorders

The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.

30 Jun 2013

Mount Sinai becomes first NYC medical center to use new HeartMate II controller in heart failure patients

The Mount Sinai Medical Center is the first medical center in New York City to offer the newly FDA approved HeartMate II® Pocket Controller™ to help its advanced heart failure patients maintain more active lifestyles.

29 Jun 2013

Innovative procedure for atrial fibrillation reduces risk for stroke

The UNC Center for Heart and Vascular Care is the first in North Carolina to use an innovative procedure for people at risk for stroke.

28 Jun 2013

Eisai submits BELVIQ NDS with Health Canada

Arena Pharmaceuticals, Inc. announced today that Eisai Limited (based in Mississauga, Ontario), a subsidiary of Eisai Inc., has submitted a New Drug Submission for BELVIQ (lorcaserin HCl) with Health Canada.

26 Jun 2013

Weill Cornell researchers discover high burden of hypertension in sub-Saharan African country

Based on the experience of a large hospital in Tanzania, Weill Cornell Medical College researchers have discovered a "startlingly" high burden of hypertension in this sub-Saharan African country.

26 Jun 2013

Hospital performance on publicly reported conditions may be correlated with overall mortality rates

Hospital performance on publicly reported conditions (acute myocardial infarction [heart attack], congestive heart failure, and pneumonia), may potentially be used as a signal of overall hospital mortality rates, according to a study by Marta L. McCrum, M.D., of Harvard School of Public Health, Boston, and colleagues.

25 Jun 2013

New ESC cardiac pacing and resynchronization guidelines presented at EHRA EUROPACE meeting

The 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy- developed in collaboration with the European Heart Rhythm Association, have created a new classification system for bradyarrhythmias according to mechanisms rather than aetiology.

25 Jun 2013

New model developed to predict atrial fibrillation stroke risk factors

A more accurate and reliable stroke prediction model has been developed to help physicians decide whether to start blood-thinning treatment for patients with atrial fibrillation, as described in the current online issue of the Journal of the American Heart Association.

21 Jun 2013

Researchers monitor dynamic cellular events that take place during cardiac regeneration in zebrafish

In a study published in the June 19 online edition of the journal Nature, a scientific team led by researchers from the University of California, San Diego School of Medicine visually monitored the dynamic cellular events that take place when cardiac regeneration occurs in zebrafish after cardiac ventricular injury. Their findings provide evidence that various cell lines in the heart are more plastic, or capable of transformation into new cell types, than previously thought.

20 Jun 2013

Nitrous oxide does not increase heart attack risk, study finds

Nitrous oxide - best known as laughing gas - is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk of a heart attack during surgery or soon afterward. But those fears are unfounded, a new study indicates.

19 Jun 2013

Heart Failure News and Research

Further Reading

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Drugs used to control BP associated with lower risk of heart failure in diabetic patients

Capricor to become wholly-owned subsidiary of Nile Therapeutics

Saint Luke's Hospital opens Charles & Barbara Duboc Cardio Health & Wellness Center

Study says screening heart with natriuretic peptide may reduce risk of dysfunction, heart failure

Fondation Leducq grants $6M to cardiovascular scientists to help advance cardiac regeneration therapeutics

Hospitals, doctors consider changes amid Medicare hospital readmissions scrutiny

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

First Edition: July 1, 2013

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Study shows lymphatic circulatory system may be intimately involved in vascular disorders

Mount Sinai becomes first NYC medical center to use new HeartMate II controller in heart failure patients

Innovative procedure for atrial fibrillation reduces risk for stroke

Eisai submits BELVIQ NDS with Health Canada

Weill Cornell researchers discover high burden of hypertension in sub-Saharan African country

Hospital performance on publicly reported conditions may be correlated with overall mortality rates

New ESC cardiac pacing and resynchronization guidelines presented at EHRA EUROPACE meeting

New model developed to predict atrial fibrillation stroke risk factors

Researchers monitor dynamic cellular events that take place during cardiac regeneration in zebrafish

Nitrous oxide does not increase heart attack risk, study finds

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News